Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (16 ops.)
Latest filing published 27 Aug 2026 for Hims & Hers Health, Inc.. Read the official filing
Filing timeline
BuySaleAndrew Dudum
Insider track record
Disclosed buys
2
Disclosed sells
16
T+90 hit rate
0%
T+90 mean return
-23.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Andrew Dudum: trading record in brief
Andrew Dudum, listed as chief executive, appears in our data through filings on Hims & Hers Health, Inc. shares, published by SEC (Form 4). Between 20 May 2021 and 27 August 2026, the trades on record add up to 84 filings.
Both buying and selling appear: 2 purchases worth €432k, against 16 sales worth €40.8M. Sales outweigh purchases by €40.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 share grants and 54 option exercises.
The record was last updated on 27 August 2026 with a transaction in Hims & Hers Health, Inc. The last insider purchase was made public on 8 February 2022, 1,713 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew Dudum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations84 total
463,289 shares0Class A Common StockSEC:0001773751-26-000217:0
977,566 shares0Class A Common StockSEC:0001773751-26-000217:1
154,993 sharesClass A Common StockSEC:0001773751-26-000212:0
78,859 shares@ US$28.150.034% mcap3.1% of flowClass A Common StockSEC:0001773751-26-000212:1
154,991 sharesClass A Common StockSEC:0001773751-26-000126:0
85,632 sharesClass A Common StockSEC:0001773751-26-000126:1
422,933 sharesClass A Common StockSEC:0001773751-26-000053:0
422,933 sharesClass A Common StockSEC:0001773751-26-000053:1
436,190 shares@ US$24.7715.7% of flowClass A Common StockSEC:0001837796-26-000004:0
794,002 shares0Class A Common StockSEC:0001837796-26-000002:0
164,369 sharesClass A Common StockSEC:0001773751-25-000386:0
1,078,549 shares0Class A Common StockSEC:0001773751-25-000370:0
262,423 shares0Class A Common StockSEC:0001773751-25-000357:0
2,792 shares@ US$62.65180.2% of flowClass A Common StockSEC:0001773751-25-000342:0
65,110 shares@ US$50.57450.051% mcap22.2% of flowClass A Common StockSEC:0001773751-25-000311:0
164,368 sharesClass A Common StockSEC:0001773751-25-000301:0
47,534 shares@ US$45.05183.1% of flowClass A Common StockSEC:0001773751-25-000280:0
660,000 shares@ US$50.58259.0% of flowClass A Common StockSEC:0001773751-25-000273:0
17,001 shares@ US$2.430.2% of flowClass A Common StockSEC:0001773751-25-000237:0
2,792 shares@ US$50.5790.6% of flowClass A Common StockSEC:0001773751-25-000235:0
164,368 sharesClass A Common StockSEC:0001773751-25-000222:0
2,792 shares@ US$59.27010.6% of flowClass A Common StockSEC:0001773751-25-000165:0
41,667 shares@ US$2.430.3% of flowClass A Common StockSEC:0001773751-25-000141:0
41,667 shares@ US$30.1864.2% of flowClass A Common StockSEC:0001773751-25-000141:1
50,000 shares@ US$2.430.4% of flowClass A Common StockSEC:0001773751-25-000141:2
25 of 84 declarations
